Organogenesis Holdings Inc (ORGO)
4.00
-0.43
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Profit Margin (Quarterly): -13.09% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -13.09% |
March 31, 2024 | -1.91% |
December 31, 2023 | -0.57% |
September 30, 2023 | 2.92% |
June 30, 2023 | 4.53% |
March 31, 2023 | -2.76% |
December 31, 2022 | 6.48% |
September 30, 2022 | 0.18% |
June 30, 2022 | 7.20% |
March 31, 2022 | -0.94% |
December 31, 2021 | 39.88% |
September 30, 2021 | 11.06% |
June 30, 2021 | 16.79% |
March 31, 2021 | 9.70% |
December 31, 2020 | 17.15% |
September 30, 2020 | 20.59% |
Date | Value |
---|---|
June 30, 2020 | -7.49% |
March 31, 2020 | -26.43% |
December 31, 2019 | -3.55% |
September 30, 2019 | -16.71% |
June 30, 2019 | -14.86% |
March 31, 2019 | -27.42% |
December 31, 2018 | -14.55% |
September 30, 2018 | -25.76% |
June 30, 2018 | -45.95% |
March 31, 2018 | -63.29% |
December 31, 2017 | -3.42% |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | -12.22% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-26.43%
Minimum
Mar 2020
39.88%
Maximum
Dec 2021
4.20%
Average
2.92%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
Poseida Therapeutics Inc | -120.8% |
NovaBay Pharmaceuticals Inc | -66.04% |
Palatin Technologies Inc | -2.36K% |
iBio Inc | -4.44K% |
Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -6.05% |
Return on Assets | -3.64% |
Return on Invested Capital | -4.87% |
Gross Profit Margin (Quarterly) | 77.58% |
Operating Margin (Quarterly) | 6.84% |
Return on Net Operating Assets | -5.17% |